These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 30216413

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. L-Arginine Affects Aerobic Capacity and Muscle Metabolism in MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes) Syndrome.
    Rodan LH, Wells GD, Banks L, Thompson S, Schneiderman JE, Tein I.
    PLoS One; 2015; 10(5):e0127066. PubMed ID: 25993630
    [Abstract] [Full Text] [Related]

  • 3. Comparison of magnetic resonance spectroscopy (MRS) with arterial spin labeling (ASL) in the differentiation between mitochondrial encephalomyopathy, lactic Acidosis, plus stroke-like episodes (MELAS) and acute ischemic stroke (AIS).
    Li X, Wang Y, Wang Z, Lu J, Xu Y, Ye J, Kuang Z, Li B, Pan M, Chen W, Lu S, Zhou Z, Cheng L, Wang H.
    J Clin Neurosci; 2018 Sep; 55():65-70. PubMed ID: 29921486
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mitochondrial dysfunction and cerebral metabolic abnormalities in patients with mitochondrial encephalomyopathy subtypes: Evidence from proton MR spectroscopy and muscle biopsy.
    Niu FN, Meng HL, Chang LL, Wu HY, Li WP, Liu RY, Wang HT, Zhang B, Xu Y.
    CNS Neurosci Ther; 2017 Aug; 23(8):686-697. PubMed ID: 28695670
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. L-arginine is effective in stroke-like episodes of MELAS associated with the G13513A mutation.
    Shigemi R, Fukuda M, Suzuki Y, Morimoto T, Ishii E.
    Brain Dev; 2011 Jun; 33(6):518-20. PubMed ID: 20832210
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. 8-year retrospective analysis of intravenous arginine therapy for acute metabolic strokes in pediatric mitochondrial disease.
    Ganetzky RD, Falk MJ.
    Mol Genet Metab; 2018 Mar; 123(3):301-308. PubMed ID: 29428506
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Magnetic resonance spectroscopy: use in monitoring MELAS treatment.
    Pavlakis SG, Kingsley PB, Kaplan GP, Stacpoole PW, O'Shea M, Lustbader D.
    Arch Neurol; 1998 Jun; 55(6):849-52. PubMed ID: 9626777
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Therapeutic regimen of L-arginine for MELAS: 9-year, prospective, multicenter, clinical research.
    Koga Y, Povalko N, Inoue E, Nakamura H, Ishii A, Suzuki Y, Yoneda M, Kanda F, Kubota M, Okada H, Fujii K.
    J Neurol; 2018 Dec; 265(12):2861-2874. PubMed ID: 30269300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.